TPX2 expression is associated with poor survival in gastric cancer

被引:0
作者
Chiharu Tomii
Mikito Inokuchi
Yoko Takagi
Toshiaki Ishikawa
Sho Otsuki
Hiroyuki Uetake
Kazuyuki Kojima
Tatsuyuki Kawano
机构
[1] Tokyo Medical and Dental University,Department of Gastrointestinal Surgery
[2] Tokyo Medical and Dental University,Department of Surgical Specialties
[3] Tokyo Medical and Dental University,Department of Minimally Invasive Surgery
来源
World Journal of Surgical Oncology | / 15卷
关键词
TPX2; Prognostic marker; Immunohistochemistry; Gastric cancer;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 126 条
[1]  
Ferlay J(2015)Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 Int J Cancer 136 E359-86
[2]  
Soerjomataram I(2009)Gastric cancer Lancet 374 477-90
[3]  
Dikshit R(2010)Phase II study of oxaliplatin plus S-1 as first-line treatment for advanced gastric cancer (G-SOX study) Ann Oncol 21 1001-5
[4]  
Eser S(2008)Capecitabine and oxaliplatin for advanced esophagogastric cancer N Engl J Med 358 36-46
[5]  
Mathers C(2008)S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial Lancet Oncol 9 215-21
[6]  
Rebelo M(1998)Genetic instabilities in human cancers Nature 396 643-9
[7]  
Hartqrink HH(2006)A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers Nat Genet 38 1043-8
[8]  
Jansen EP(2002)Chromosome-induced microtubule assembly mediated by TPX2 is required for spindle formation in HeLa cells Nat Cell Biol 4 871-9
[9]  
van Grieken NC(2012)Mitotic stress and chromosomal instability in cancer: the case for TPX2 Genes Cancer 3 721-30
[10]  
van de Velde CJ(2014)TPX2: of spindle assembly, DNA damage response, and cancer Cell Mol Life Sci 71 3027-47